- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Fresenius SE & Co KGAA O.N. (FREG)
Track today's live Fresenius SE (FREG) share price, performance and key data on this page with our current Xetra:FREG stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Fresenius SE share price on the Xetra exchange. Use the dropdown to switch exchange for the FREG share price, head to our technical summary section, which provides analysis on Fresenius SE share price buy/sell indicators using real-time data (or discuss the Fresenius SE (FREG) stock price today with other investors in the Fresenius SE ETR share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ETR:FREG share price (ISIN: DE0005785604) to enhance your trading decisions with our free investment tools and resources.
What Is the Fresenius SE & Co KGAA O.N. Share Price Today?
The Fresenius SE share price today is 42.400.
What Is the Stock Symbol for Fresenius SE & Co KGAA O.N.
The stock symbol (or 'ticker') for Fresenius SE & Co KGAA O.N. is "FREG."
What Stock Exchange Does Fresenius SE & Co KGAA O.N. Trade On?
Fresenius SE & Co KGAA O.N. is listed and trades on the Xetra stock exchange.
Is Fresenius SE & Co KGAA O.N. a Good Stock to Buy?
Determining whether Fresenius SE (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current ETR:FREG share price (ISIN: DE0005785604) to enhance your trading decisions with our free investment tools and resources.
What Is the Fresenius SE & Co KGAA O.N. Share Price Today?
The Fresenius SE share price today is 42.400.
What Is the Stock Symbol for Fresenius SE & Co KGAA O.N.
The stock symbol (or 'ticker') for Fresenius SE & Co KGAA O.N. is "FREG."
What Stock Exchange Does Fresenius SE & Co KGAA O.N. Trade On?
Fresenius SE & Co KGAA O.N. is listed and trades on the Xetra stock exchange.
Is Fresenius SE & Co KGAA O.N. a Good Stock to Buy?
Determining whether Fresenius SE (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
42.400
-1.010(-2.33%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.350
43.010
52 wk Range
35.110
52.960
FREG is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.35043.010
52 wk Range
35.11052.960
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.43%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.43%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
FREG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
54.221
Upside
+27.88%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
13 Buy
1 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 54.221
(+27.88% Upside)
Earnings
Latest Release
06/05/2026
EPS / Forecast
0.82 / 0.89
Revenue / Forecast
5.74B / 5.83B
Compare FREG to Peers and Sector
Metrics to compare | FREG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFREGPeersSector | |
|---|---|---|---|---|
P/E Ratio | 15.9x | 18.6x | −0.4x | |
PEG Ratio | 0.07 | 0.25 | 0.00 | |
Price/Book | 1.2x | 1.8x | 2.6x | |
Price / LTM Sales | 1.0x | 1.8x | 3.0x | |
Upside (Analyst Target) | 25.5% | 27.1% | 49.7% | |
Fair Value Upside | Unlock | 26.6% | 7.3% | Unlock |
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids. It also provides biosimilar drugs; enteral and parenteral nutrition products; and medical technologies that include disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment operates hospitals, medical care centers, occupational health centers, prevention centers, and outpatient health centers, as well as provision of medical diagnostics. The company has a strategic collaboration with SAP SE and Avelios Medical GmbH for the development of a cloud-native, modular hospital information system that enables digitalization of clinical and administrative processes with AI integration. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Fresenius SE (Xetra: FREG) Share Price Today?
The Fresenius SE stock price today is 42.400 EUR.
What Stock Exchange Does Fresenius SE (FREG) Trade On?
Fresenius SE is listed and trades on the Frankfurt Stock Exchange.
What Is the Ticker (Stock Symbol) for Fresenius SE?
The stock symbol (also called a 'ticker') for Fresenius SE is "FREG."
Does Fresenius SE Pay Dividends? What’s The Current FREG Dividend Yield?
Yes, FREG Pays Dividends to its Shareholders. The current Fresenius SE dividend yield is 2.43%.
What Is the Current Fresenius SE Market Capitalisation?
As of today, Fresenius SE (Xetra: FREG) market cap is 23.930B EUR.
What Is Fresenius SE's (FREG) Earnings Per Share (TTM)?
The Fresenius SE EPS is currently 2.688 (Trailing Twelve Months).
When Is the Next Fresenius SE Earnings Date?
Fresenius SE's next earnings report will be released on 05/08/2026.
Is FREG a Buy or Sell From a Technical Analyst Perspective?
Based on today's Fresenius SE moving averages and other technical indicators, the daily buy/sell signal for FREG stock is Strong Buy.
How Many Times Has Fresenius SE Stock Split?
Fresenius SE has split 4 times. (See the FREG stock split history page for full effective split date and price information.)
How Many Employees Does Fresenius SE Have?
Fresenius SE has 177783 employees, based on their latest Companies House report.
What is the current trading status of Fresenius SE (Xetra: FREG)?
As of 08/07/2026, Fresenius SE (FREG) is trading at a share price of 42.400 EUR, with a previous close of 42.400 EUR. The stock has fluctuated within a day range of 42.350 EUR to 43.010 EUR, while its 52-week range spans from 35.110 EUR to 52.960 EUR.
What Is Fresenius SE (FREG) Price Target According to Analysts?
The average 12-month price target for Fresenius SE is 54.221 EUR, with a high estimate of 59 EUR and a low estimate of 48 EUR. 13 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +27.88% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.